A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a randomized, double-blind, placebo-controlled, phase 1b study designed to evaluate safety, tolerability, PK, and preliminary efficacy of APL-1401 in patients with moderately to severely active UC. This study comprises 3 periods including screening period (D-28\~D-1), treatment period (D1-D28), and safety follow-up period(D29-D58).
Epistemonikos ID: 2a185432b6c60a1da8ae1d4246b49319d22100e9
First added on: Sep 07, 2023